AC Immune SA

DB:IMR Stock Report

Market Cap: €201.1m

AC Immune Management

Management criteria checks 3/4

AC Immune's CEO is Andrea Pfeifer, appointed in Apr 2003, has a tenure of 7.92 years. total yearly compensation is CHF1.57M, comprised of 35.6% salary and 64.4% bonuses, including company stock and options. directly owns 2.58% of the company’s shares, worth €5.18M. The average tenure of the management team and the board of directors is 5.2 years and 6 years respectively.

Key information

Andrea Pfeifer

Chief executive officer

CHF1.6m

Total compensation

CEO salary percentage35.6%
CEO tenure21yrs
CEO ownership2.6%
Management average tenure5.2yrs
Board average tenure6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Andrea Pfeifer's remuneration changed compared to AC Immune's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-CHF54m

Sep 30 2023n/an/a

-CHF68m

Jun 30 2023n/an/a

-CHF67m

Mar 31 2023n/an/a

-CHF69m

Dec 31 2022CHF2mCHF558k

-CHF71m

Sep 30 2022n/an/a

-CHF73m

Jun 30 2022n/an/a

-CHF76m

Mar 31 2022n/an/a

-CHF75m

Dec 31 2021CHF2mCHF530k

-CHF73m

Sep 30 2021n/an/a

-CHF71m

Jun 30 2021n/an/a

-CHF74m

Mar 31 2021n/an/a

-CHF71m

Dec 31 2020CHF2mCHF520k

-CHF62m

Sep 30 2020n/an/a

-CHF62m

Jun 30 2020n/an/a

-CHF25m

Mar 31 2020n/an/a

-CHF26m

Dec 31 2019CHF2mCHF510k

CHF45m

Sep 30 2019n/an/a

CHF50m

Jun 30 2019n/an/a

CHF18m

Mar 31 2019n/an/a

CHF24m

Dec 31 2018CHF2mCHF455k

-CHF51m

Sep 30 2018n/an/a

-CHF32m

Jun 30 2018n/an/a

-CHF27m

Mar 31 2018n/an/a

-CHF29m

Dec 31 2017CHF2mCHF404k

-CHF26m

Compensation vs Market: Andrea's total compensation ($USD1.72M) is above average for companies of similar size in the German market ($USD678.96K).

Compensation vs Earnings: Andrea's compensation has been consistent with company performance over the past year.

CEO

Andrea Pfeifer (66 yo)

21yrs

Tenure

CHF1,568,000

Compensation

Prof. Dr. Andrea Pfeifer, Ph.D. has been the Chief Executive Officer of AC Immune SA since 2003. Prof. Dr. Pfeifer Co-founded AC Immune SA in April 2003. She serves as an Advisor and Chairwoman of BioMedPa...

Leadership Team

NamePositionTenureCompensationOwnership
Andrea Pfeifer
Co-Founder21yrsCHF1.57m2.58%
CHF 5.2m
Christopher Roberts
CFO & VP of Finance2yrsno data0.013%
CHF 27.0k
Piergiorgio Donati
Chief Technical Operations Officer5.2yrsno data0.026%
CHF 52.5k
Jean-Fabien Monin
Chief Administrative Officer8.8yrsno data0.33%
CHF 667.8k
Howard Donovan
Chief HR Officer2yrsno data0.021%
CHF 43.1k
Madiha Derouazi
Chief Scientific Officerless than a yearno data0.0034%
CHF 6.8k
Gary Waanders
Senior VP of Investor Relations & Corporate Communicationsno datano datano data
Alexandre Caratsch
General Counselno datano datano data
Julian Snow
VP of U.S. Finance & Corporate Development2yrsno datano data
David Hickman
Head of AD - SME14.3yrsno datano data
Joseph Wettstein
Head of Non-AD Proteinopathies & Deputy Chief Scientific Officer8.2yrsno datano data
Oliver Sol
VP & Head of Clinical Developmentno datano datano data

5.2yrs

Average Tenure

53.5yo

Average Age

Experienced Management: IMR's management team is seasoned and experienced (5.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Andrea Pfeifer
Co-Founder7.9yrsCHF1.57m2.58%
CHF 5.2m
Jean-Marie Lehn
Chairman of Scientific Advisory Boardno datano datano data
Claude Nicolau
Member of Scientific Advisory Boardno datano datano data
Douglas Williams
Independent Non-Executive Chairman6yrsCHF194.00k0.041%
CHF 83.3k
Alf E. Lindberg
Member of Scientific Advisory Boardno datano datano data
Detlev Riesner
Member of Scientific Advisory Boardno dataCHF5.00kno data
Fred Van Leuven
Member of Scientific Advisory Boardno dataCHF105.00kno data
I. Rosenberg
Member of Scientific Advisory Boardno datano datano data
M. Monsigny
Member of Scientific Advisory Boardno datano datano data
E. Lestringant
Member of Scientific Advisory Boardno datano datano data
Monika Butler
Independent Vice Chair2.5yrsCHF208.00k0.0097%
CHF 19.6k
Andreas Monsch
Head of Clinical Advisory Boardno datano datano data

6.0yrs

Average Tenure

73.5yo

Average Age

Experienced Board: IMR's board of directors are considered experienced (6 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.